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ABSTRACT
Reporting of observational studies in veterinary research presents challenges that often are not addressed in published
reporting guidelines. Our objective was to develop an extension of the STROBE (Strengthening the Reporting of
Observational Studies in Epidemiology) statement that addresses unique reporting requirements for observational studies in
veterinary medicine related to health, production, welfare, and food safety. We conducted a consensus meeting with 17 experts
in Mississauga, Canada. Experts completed a premeeting survey about whether items in the STROBE statement should be
modified or added to address unique issues related to observational studies in animal species with health, production, welfare,
or food safety outcomes. During the meeting, each STROBE item was discussed to determine whether or not rewording was
recommended, and whether additions were warranted. Anonymous voting was used to determine consensus. Six items required
no modifications or additions. Modifications or additions were made to the STROBE items 1 (title and abstract), 3 (objectives),
5 (setting), 6 (participants), 7 (variables), 8 (data sources and measurement), 9 (bias), 10 (study size), 12 (statistical methods),
13 (participants), 14 (descriptive data), 15 (outcome data), 16 (main results), 17 (other analyses), 19 (limitations), and 22
(funding). The methods and processes used were similar to those used for other extensions of the STROBE statement. The use
of this STROBE statement extension should improve reporting of observational studies in veterinary research by recognizing
unique features of observational studies involving food-producing and companion animals, products of animal origin,
aquaculture, and wildlife.
Observational studies are a common methodological
approach in veterinary research and have been used to
estimate the frequency of a disease or condition, test
hypotheses, generate new hypotheses, or generate data
suitable as input for systematic reviews and meta-analyses,
risk assessments, and other data-dependent models, such as
mathematical and simulated disease models. Thus, observa-
tional studies may be used to estimate the prevalence or
incidence of a condition, to investigate the distribution of
conditions in time and space, to explore risk factors and
compare management options, to create explanatory models,
or to evaluate diagnostic test accuracy. Comprehensive and
transparent reporting of an observational study’s design,
execution, and results is essential for the interpretation of the
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research in terms of evaluating its applicability for the reader
and its potential for bias and for the data to be used as input
for other studies, such as meta-analyses and risk assess-
ments. The peer-review process also benefits from guide-
lines describing appropriate reporting. In human health care,
inadequacies in reporting of key information in observa-
tional studies have been documented (6, 15, 21). Although
there is less documented empirical evidence of deficiencies
in reporting observational studies in veterinary medicine,
absence of evidence is not evidence of absence. Indeed,
some evidence of inadequate reporting exists in the literature
on preharvest food safety (19).
The STROBE statement (www.strobe-statement.org)
was developed to provide guidance for the reporting of
observational studies related to human health. It consists of a
22-item checklist that is accompanied by a document
describing the development of the STROBE statement (24)
and an elaboration document that provides explanations of
each item, as well as examples of complete reporting of each
item (23). The STROBE guidelines focus on cohort, case-
control, and cross-sectional studies of aspects of human
medicine and public health, although many of the principles
also apply to other observational study designs, such as
hybrid designs or ecological studies. The STROBE
statement has been modified for use in specific content
areas within epidemiology, including genetic-association
studies (STREGA) (8), molecular epidemiology (STROBE-
ME) (5), and molecular epidemiology for infectious diseases
(STROME-ID) (4).
There are some nuances of conducting and reporting
studies in animal populations that are unique from other
areas of epidemiology (17). Thus, the CONsolidated
Standards Of Reporting Trials (CONSORT) statement for
reporting randomized controlled trials in human medicine
(9) was previously modified for use in veterinary medicine.
The result was the creation and publication of the reporting
guidelines for randomized controlled trials for livestock and
food safety (REFLECT) statement (14, 18). Similarly, while
the STROBE statement and the accompanying elaboration
document provide an excellent resource for conducting,
reporting, and reading observational studies, modifications
to address specific issues in veterinary medicine will
increase its applicability in this field (17).
Here, we describe the methods and processes used to
develop an extension of the STROBE statement that forms
the basis for the standardized reporting guidelines for
observational studies in veterinary medicine (STROBE-
Vet). As a separate companion paper, the STROBE-Vet
explanation and elaboration document (11, 12) provides the
methodological background for the items contained in the
STROBE-Vet statement, as well as illustrative examples of
appropriate reporting. We strongly recommend that the
STROBE-Vet checklist be used in conjunction with the
explanation and elaboration document for all observational
studies related to animal health, production, welfare, or food
safety outcomes.
MATERIALS AND METHODS
The process for extending reporting-guideline statements
(e.g., STROBE and CONSORT) to meet the specific needs of
individual disciplines has been documented (1, 10). We used these
reports to design the approach used for developing the statement
reported herein.
Steering committee. A steering committee was responsible
for the development of the revised veterinary extension of the
STROBE statement. This group, composed of four members
(coauthors J.M.S., A.M.O.C., H.N.E., and I.R.D.), first met to
discuss the idea in December 2012. The committee agreed to
explore the need for modifying the original STROBE statement
and to use the approach reported previously as a guideline for the
modification (10). The committee secured funding for the project,
identified potential participants, invited the potential participants to
attend a consensus meeting, organized the meeting, and was
responsible for subsequent steps involved in preparation and
publication of the papers as detailed below.
Funding. Funding was required to cover the costs of the
consensus meeting (e.g., travel, accommodations, and meeting
rooms). The decision was made by the steering committee not to
seek funding from pharmaceutical or biological companies
commonly associated with veterinary research. Efforts to obtain
funding were limited to not-for-profit nongovernment organiza-
tions, academic institutions, and a publishing company. Funding
was received from the Canadian Association for Veterinary
Epidemiology and Preventive Medicine (CAVEPM), the Centre
for Veterinary Epidemiology (CVER) at the University of Prince
Edward Island, the Centre for Public Health and Zoonoses
(CPHAZ) at the University of Guelph, Iowa State University,
Cornell University, and the publishing company VER Inc, Prince
Edward Island, Canada. Sufficient funds were obtained to pay for
all local expenses for the participants at the consensus meeting.
Funds to cover travel costs for participants were not obtained;
therefore, in general, participants fully funded their own travel and
the sources of these funds were not identified.
Identification of participants. The committee’s aim was to
bring together a group of experts familiar with the design, conduct,
and statistical analysis of observational studies concerning animal
health, production, welfare, and food safety. Another aim was to
include researchers with experience in a wide variety of areas,
including food-animal production, companion-animal medicine,
veterinary public health, and food safety. Representation from
multiple countries was sought, with an effort to include several
participants with relevant editorial experience.
The steering committee decided to limit the size of the
meeting to approximately 20 participants, including the four
committee members. The size limitation was based on funding and
the need for a group size that facilitated interaction and active
discussion. The steering committee identified experts for invitation
based on areas of expertise (many with multiple areas) and
geographic locations. Invitations to attend the meeting were sent
via e-mail by J.M.S. to the first 20 individuals on the list. The e-
mail invitation requested that individuals wishing to participate
commit to (i) completing a premeeting survey to determine
whether modifications to the checklist items of the STROBE
statement seemed necessary for veterinary medicine and, if so, to
suggest appropriate modifications; (ii) attending a consensus
meeting in Mississauga, Canada; and (iii) self-funding their travel
to that meeting. If an initial invitation was declined, an alternative
individual with similar expertise and from the same geographic
region was contacted using the same e-mail invitation.
The steering committee also contacted the authors of the
original STROBE statement papers to inform them of our interest
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in modifying the STROBE statement and to solicit support for, and
participation in, the initiative.
Identification of specific issues. Using the approach
described previously (10), a survey was sent to the invitees
soliciting input on each checklist item in the STROBE statement to
improve relevance to observational studies related to animal health,
production, welfare, and food safety. The intent of this survey was
to guide discussion at the consensus meeting; thus, human ethics
approval was not required. The survey was sent by e-mail as a
spreadsheet attachment to the invitees, as well as to individuals
who were invited but were unable to attend the meeting and had
indicated that they still wished to provide input by completing the
survey. The survey included the 22 items of the STROBE
statement and asked the respondents to indicate whether each item
should be modified (yes or no) and, if yes, to describe the
modifications that the respondent felt would be appropriate. At the
end of each section (Abstract, Introduction, Methods, Results,
Discussion, and Conclusion), space was provided for the
respondents to propose additional items of relevance for reporting
on studies related to animal health, production, welfare, or food
safety.
After the surveys were returned, the responses for each
checklist item were anonymously compiled.
The consensus meeting. A 2½-day consensus meeting was
held on 11 to 13 May 2014, in Mississauga, Ontario, Canada, with
a total of 17 participants from Australia, Canada, Denmark, the
United Kingdom, and the United States, as well as two assistants
for logistical support and documentation. Prior to the meeting,
participants were provided with an electronic copy of the STROBE
statement (24) and its elaboration document (23), as well as the
results of the survey. At the meeting, participants were provided
with the same materials in printed form.
The meeting began with an evening session consisting of
introductions, an overview presentation on reporting guidelines in
general and their relevance to veterinary medicine, and a
discussion of the format for the meeting, the scope of the initiative,
and the expectations of the participants in the guideline-
development process. This included a discussion and vote on the
approach that would be used to reach consensus. To facilitate
confidential voting and recording of the voting results throughout
the meeting, electronic remote voting devices were used. Three
voting criteria were discussed as indicators of consensus:
unanimous agreement among the 17 experts minus 2 (88%),
minus 3 (82%), or minus 5 (70%). The participants agreed that a
unanimous vote minus three persons would be required for
consensus. In some instances, experts would leave the room for
brief periods. In this case, at least 16 experts had to participate in
each vote, with unanimous vote minus three still defining
consensus.
At the start of the first full day of discussion, two of the
authors (M.C. and M.E.) of the STROBE statement papers
attended by teleconference. They provided an overview of the
process for developing the STROBE statement, common uses and
misuses, and a discussion of STROBE statement extensions.
For the remainder of the meeting, the following approach was
used for the STROBE statement checklist items 1 through 22.
Initially, the moderator described the item, the key elements of that
item as presented in the STROBE elaboration document, and the
suggestions from the premeeting survey for modifying that item.
The discussion sessions were moderated alternately by one of two
members of the steering committee (J.M.S. and A.M.O.C.). The
moderator facilitated a group discussion of the key elements,
including a discussion as to whether the proposed modifications
should result in modification of the wording of the STROBE item.
Following the discussion, participants (including both moderators)
voted to accept or reject the modifications to the wording of the
statement item. If there were no modifications proposed, the vote
was to accept the item as originally written. If an item received
sufficient votes to indicate consensus, it was accepted. If the item
did not receive a consensus vote, it was tabled for further
discussion at the end of the meeting. After the completion of voting
on each item, a discussion of the key elements that should be
considered within the elaboration document occurred. Participants
were also asked to provide written suggestions for discussion
points to include in the elaboration document. Two nonvoting
assistants served as record keepers to record the results of the
voting, take notes of the discussion, and collect additional written
suggestions on each item from the participants.
Preparation of reporting guidelines. After the meeting, the
steering committee compiled a draft report of the meeting that
included the proposed modifications to the STROBE statement, a
summary of the suggestions for the elaboration document, and a
request for feedback from the participants. The steering committee
collated the comments and suggested revisions, and developed the
modified STROBE statement for observational studies in veteri-
nary medicine related to animal health, production, welfare, or
food safety outcomes. A draft of the STROBE-Vet statement was
previewed by graduate students (see details in the ‘‘Results’’
section). A draft of the elaboration document was then prepared by
the steering committee and was circulated among the participants
for input.
RESULTS
In total, 23 experts were invited to participate in the
consensus meeting and 14 accepted, though one invitee was
subsequently unable to attend. The nine individuals who
declined had other commitments, including teaching obli-
gations during the time of the consensus meeting. All four of
the steering committee members attended, for a total of 17
participants. The methodological expertise of the partici-
pants included epidemiology, statistics, systematic review
and meta-analysis, and risk assessment, with content
expertise in food safety, health, production, and welfare in
food-producing, companion and recreation animals (e.g.,
dogs, cats, and horses), aquaculture, and wildlife. The group
was composed of seven individuals working in Canada, five
from the United States, four from Europe, and one from
Australia. There were 13 academicians, three emeritus
academicians, and one government employee. Members of
the STROBE group were consulted throughout the process,
and two members (M.C. and M.E.) participated in the first
morning of the consensus meeting.
Nineteen premeeting surveys were completed by 12 of
the 13 invitees, all four steering committee members, and
three additional individuals who were invited to the
consensus meeting but were unable to attend. The individual
who accepted the invitation but was subsequently unable to
attend the meeting did not complete the premeeting survey.
The participants agreed that the scope would include
observational studies using samples and information of
animal origin with outcomes related to animal health,
production, welfare, or food safety. This wording was
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TABLE 1. Modifications to the original STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement
checklist for the STROBE-Vet statement
Item STROBE recommendation STROBE-Vet recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly
used term in the title or the abstract
(a) Indicate that the study was an observational
study and, if applicable, use a common study
design terma
(b) Provide in the abstract an informative and
balanced summary of what was done and what
was found
(b) Indicate why the study was conducted, the
design, the results, the limitations, and the
relevance of the findings
Introduction
Background/
rationale
2 Explain the scientific background and rationale for
the investigation being reported
Explain the scientific background and rationale for
the investigation being reported
Objectives 3 State specific objectives, including any prespecified
hypotheses
(a) State specific objectives, including any primary
or secondary prespecified hypotheses or their
absence
(b) Ensure that the level of organization is clear for
each objective and hypothesisb
Methods
Study design 4 Present key elements of study design early in the
paper
Present key elements of study design early in the
paper
Setting 5 Describe the setting, locations, and relevant dates,
including periods of recruitment, exposure,
follow-up, and data collection
(a) Describe the setting, locations, and relevant
dates, including periods of recruitment, exposure,
follow-up, and data collection
(b) If applicable, include information at each level
of organization
Participantsc 6 (a) Cohort study—Give the eligibility criteria, and
the sources and methods of selection of
participants. Describe methods of follow-up
(a) Describe the eligibility criteria for the owners/
managers and for the animals, at each relevant
level of organization
Case-control study—Give the eligibility criteria,
and the sources and methods of case
ascertainment and control selection. Give the
rationale for the choice of cases and controls
Cross-sectional study—Give the eligibility criteria,
and the sources and methods of selection of
participants
(b) Cohort study—For matched studies, give
matching criteria and number of exposed and
unexposed
(b) Describe the sources and methods of selection
for the owners/managers and for the animals, at
each relevant level of organization
Case-control study—For matched studies, give
matching criteria and the number of controls per
case
(c) Describe the method of follow-up
(d) For matched studies, describe matching criteria
and the number of matched individuals per
subject (e.g., number of controls per case)
Variables 7 Clearly define all outcomes, exposures, predictors,
potential confounders, and effect modifiers. Give
diagnostic criteria, if applicable
(a) Clearly define all outcomes, exposures,
predictors, potential confounders, and effect
modifiers. If applicable, give diagnostic criteria
(b) Describe the level of organization at which each
variable was measured
(c) For hypothesis-driven studies, the putative
causal-structure among variables should be
described (a diagram is strongly encouraged)
Data sources/
measurement
8d For each variable of interest, give sources of data
and details of methods of assessment
(measurement). Describe comparability of
assessment methods if there is more than one
group
(a) For each variable of interest, give sources of
data and details of methods of assessment
(measurement). If applicable, describe
comparability of assessment methods among
groups and over time
(b) If a questionnaire was used to collect data,
describe its development, validation, and
administration
(c) Describe whether or not individuals involved in
data collection were blinded, when applicable
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TABLE 1. Continued
Item STROBE recommendation STROBE-Vet recommendation
(d) Describe any efforts to assess the accuracy of
the data (including methods used for ‘‘data
cleaning’’ in primary research, or methods used
for validating secondary data)
Bias 9 Describe any efforts to address potential sources of
bias
Describe any efforts to address potential sources of
bias due to confounding, selection, or information
bias
Study size 10 Describe how the study size was arrived at (a) Describe how the study size was arrived at for
each relevant level of organization
(b) Describe how nonindependence of
measurements was incorporated into sample-size
considerations, if applicable
(c) If a formal sample-size calculation was used,
describe the parameters, assumptions, and
methods that were used, including a justification
for the effect size selected
Quantitative
variables
11 Explain how quantitative variables were handled in
the analyses. If applicable, describe which
groupings were chosen, and why
Explain how quantitative variables were handled in
the analyses. If applicable, describe which
groupings were chosen, and why
Statistical
methods
12 (a) Describe all statistical methods, including those
used to control for confounding
(a) Describe all statistical methods for each
objective, at a level of detail sufficient for a
knowledgeable reader to replicate the methods.
Include a description of the approaches to
variable selection, control of confounding, and
methods used to control for nonindependence of
observations
(b) Describe any methods used to examine
subgroups and interactions
(b) Describe the rationale for examining subgroups
and interactions and the methods used
(c) Explain how missing data were addressed (c) Explain how missing data were addressed
(d) Cohort study—If applicable, explain how loss
to follow-up was addressed
Case-control study—If applicable, explain how
matching of cases and controls was addressed
Cross-sectional study—If applicable, describe
analytical methods, taking account of sampling
strategy
(d) If applicable, describe the analytical approach
to loss to follow-up, matching, complex
sampling, and multiplicity of analyses
(e) Describe any sensitivity analyses (e) Describe any methods used to assess the
robustness of the analyses (e.g., sensitivity
analyses or quantitative bias assessment)
Results
Participants 13d (a) Report the numbers of individuals at each stage
of study—e.g., numbers potentially eligible,
examined for eligibility, confirmed eligible,
included in the study, completing follow-up, and
analyzed
(a) Report the numbers of owners/managers and
animals at each stage of study and at each
relevant level of organization—e.g., numbers
eligible, included in the study, completing
follow-up, and analyzed
(b) Give reasons for nonparticipation at each stage (b) Give reasons for nonparticipation at each stage
and at each relevant level of organization
(c) Consider use of a flow diagram (c) Consider use of a flow diagram and/or a
diagram of the organizational structure
Descriptive data
on exposures
and potential
confounders
14d (a) Give characteristics of study participants (e.g.,
demographic, clinical, social) and information on
exposures and potential confounders
(a) Give characteristics of study participants (e.g.,
demographic, clinical, social) and information on
exposures and potential confounders by group
and level of organization, if applicable
(b) Indicate number of participants, with missing
data for each variable of interest
(b) Indicate number of participants with missing
data for each variable of interest and at all
relevant levels of organization
(c) Cohort study—Summarize follow-up time (e.g.,
average and total amount)
(c) Summarize follow-up time (e.g., average and
total amount), if appropriate to the study design
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TABLE 1. Continued
Item STROBE recommendation STROBE-Vet recommendation
Outcome data 15d Cohort study—Report numbers of outcome events
or summary measures over time
(a) Report outcomes as appropriate for the study
design and summarize at all relevant levels of
organization
Case-control study—Report numbers in each
exposure category, or summary measures of
exposure
(b) For proportions and rates, report the numerator
and denominator
Cross-sectional study—Report numbers of outcome
events or summary measures
(c) For continuous outcomes, report the number of
observations and a measure of variability
Main results 16 (a) Give unadjusted estimates and, if applicable,
confounder-adjusted estimates and their precision
(e.g., 95% confidence interval). Make clear
which confounders were adjusted for and why
they were included
(a) Give unadjusted estimates and, if applicable,
adjusted estimates and their precision (e.g., 95%
confidence interval). Make clear which
confounders and interactions were adjusted.
Report all relevant parameters that were part of
the model
(b) Report category boundaries when continuous
variables were categorized
(b) Report category boundaries when continuous
variables were categorized
(c) If relevant, consider translating estimates of
relative risk into absolute risk for a meaningful
time period
(c) If relevant, consider translating estimates of
relative risk into absolute risk for a meaningful
time period
Other analyses 17 Report other analyses done—e.g., analyses of
subgroups and interactions, and sensitivity
analyses
Report other analyses done, such as sensitivity/
robustness analysis and analysis of subgroups
Discussion
Key results 18 Summarize key results with reference to study
objectives
Summarize key results with reference to study
objectives
Strengths and
limitations
19 Discuss limitations of the study, taking into account
sources of potential bias or imprecision. Discuss
both direction and magnitude of any potential
bias
Discuss strengths and limitations of the study,
taking into account sources of potential bias or
imprecision. Discuss both direction and
magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results,
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Give a cautious overall interpretation of results,
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Generalizability 21 Discuss the generalizability (external validity) of the
study results
Discuss the generalizability (external validity) of the
study results
Other information
Funding
Transparency
22 Give the source of funding and the role of the
funders for the present study and, if applicable,
for the original study on which the present article
is based
(a) Funding—Give the source of funding and the
role of the funders for the present study and, if
applicable, for the original study on which the
present article is based
(b) Conflicts of interest—Describe any conflicts of
interest, or lack thereof, for each author
(c) Describe the authors’ roles—Provision of an
authors’ declaration of transparency is
recommended
(d) Ethical approval—Include information on
ethical approval for use of animal and human
subjects
(e) Quality standards—Describe any quality
standards used in the conduct of the research
a Underlined text represents modifications or additions to the original STROBE wording.
b Level of organization recognizes that observational studies in veterinary research often deal with repeated measures (within an animal or
herd) or animals that are maintained in groups (such as pens and herds); thus, the observations are not statistically independent. This
nonindependence has profound implications for the design, analysis, and results of these studies.
c The word ‘‘participant’’ is used in the STROBE statement. However, for the veterinary version, it is understood that ‘‘participant’’ should
be addressed for both the animal owner or manager and for the animals themselves.
d Give such information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in
cohort and cross-sectional studies.
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meant to encompass a broad range of veterinary research
involving animals (including animal populations such as
herds, farms, or flocks), products of animal origin (such as
meat or milk), or samples from animals (such as blood or
feces). Studies involving human health outcomes related to
animal exposure were considered outside the scope of this
initiative. For these studies, the original STROBE statement
would be the appropriate guideline to use.
The participants agreed that the scope would include
both observational studies of hypotheses (hypothesis-driven
or hypothesis generating) and population-based descriptive
studies, such as those estimating the frequency and
distribution of disease. At least in the preharvest food safety
literature, it is common for disease frequency estimates to be
a key component of observational studies (19).
The majority of items (whether modified or not)
received a consensus vote the first time that a vote was
undertaken. Consensus was not achieved on the first vote for
two items: item 4 and item 9. For item 4, the discussion
revolved around whether the ‘‘key elements’’ of study
designs should be explicitly included in the item itself. For
item 9, the discussion pertained to whether euthanasia
represented a distinct source of bias (see further discussion,
below).
To meet the needs for a STROBE statement for
observational studies in veterinary research, the consensus
was that the following 16 items on the STROBE checklist
needed modification to make them more appropriate for
veterinary medicine: 1 (title and abstract), 3 (objectives), 5
(setting), 6 (participants), 7 (variables), 8 (data sources and
measurement), 9 (bias), 10 (study size), 12 (statistical
methods), 13 (participants), 14 (descriptive data), 15
(outcome data), 16 (main results), 17 (other analyses), 19
(limitations), and 22 (funding) (Table 1). The participants
identified the modification of these items as essential to the
STROBE-Vet statement checklist, rather than solely having
these issues discussed in the elaboration document.
Some of the modifications proposed to the STROBE
statement were minor wording changes intended to provide
more details for the veterinary community. For example,
item 1b (abstract) was modified to include what the
participants identified as key components of an ‘‘informative
and balanced summary’’ (the wording used in the original
STROBE statement).
Other modifications were more substantial. For in-
stance, throughout the STROBE statement, reference is
made to three common observational study designs (cohort,
case-control, and cross-sectional), with the wording of some
reporting recommendations different for the three designs.
However, in veterinary medicine, many observational
studies do not adhere strictly to one of these three classical
designs, and large population cohort studies are rare.
Therefore, the STROBE-Vet statement does not make
reference to the three common observational study designs,
but rather focuses on reporting the key features related to the
observational research. This modification impacted items 1a,
6, 12, 14, and 15 (Table 1). An example of an addition is
item 7 (variables), which now calls for the specification of
the putative causal structure (with a causal diagram being
highly encouraged) for all hypothesis-driven studies.
Another example is item 8 (data sources), which now calls
for information on questionnaire development (if relevant).
Also, throughout the STROBE statement the word ‘‘partic-
ipant’’ is used. In veterinary medicine, there generally are
two components to the concept of ‘‘participant’’: the owner
or manager of the animals included in the study population
and the animals themselves. Rather than modifying the
wording for ‘‘participant’’ throughout the checklist, a
footnote was added to note this point and to recommend
that relevant information concerning both types of ‘‘partic-
ipants’’ should be reported.
An issue that had relevance to several of the items was
that of nonindependence of observations (items 3, 5, 6, 7,
10, 12a, 13a, 13b, 13c, 14a, 14b, and 15). It is common in
veterinary medicine, particularly in livestock and shelter
medicine (where companion animals are kenneled), for
animals to be housed or managed in groups. Individuals
within groups will tend to be more similar to each other with
respect to outcome status compared to individuals in other
groups, i.e., nonindependence of observational units. It is
necessary to account for any nonindependence of the
observational units in the design, sampling strategy, and
statistical analysis to avoid violating the assumption of
independence underlying many statistical procedures. The
nonindependence of observational units may be hierarchical;
for instance, animals within pens, pens within barns, barns
within same-owner facilities. However, this is not always the
case. For example, some organizational structures may not
be purely hierarchical (e.g., cross-classified data structures),
and nonindependence can also result from repeated samples
taken over time from the same animal or facility (3). To be
consistent with the REFLECT statement (13, 18) www.
reflect-statement.org, ‘‘organizational structure’’ was used
rather than ‘‘hierarchy’’ throughout the STROBE-Vet
statement. In addition to modifying the wording of relevant
checklist items, the elaboration document includes discus-
sion of this issue.
The final item in the STROBE checklist pertains to
funding sources. The STROBE-Vet statement substantially
expands this item to encompass the broader concept of
‘‘transparency.’’ Using numbered subitems, the transparency
item addresses sources of funding, conflicts of interest,
authors’ roles, ethical approval (animal, human, or data use,
as applicable), and the use of any quality standards.
There was considerable discussion during the meeting
on the significance of euthanasia in veterinary medicine. It is
possible, and common under some disease or production
circumstances, for animals to be euthanized or electively
culled during studies. There is no equivalent to this in
human medicine; therefore, much discussion was devoted to
this topic. Although the participants agreed that the
occurrence and frequency of euthanasia or culling should
be reported in studies where it occurred, there were differing
opinions as to whether euthanasia is a distinct issue related
to the potential for information or selection bias, or whether
it is just a component of a death or survival outcome that
needs to be reported. At the end of the meeting, a vote was
held; and the consensus was to include a discussion of
euthanasia in the elaboration document but not to modify the
wording within the STROBE-Vet expansion.
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The draft statement was previewed by 17 graduate
students from two graduate student journal clubs (Epidemi-
ology Journal Club and Ruminant Group Journal Club) in
the Department of Population Medicine at the University of
Guelph. The students identified phrases for which they
would like clarification or further explanation. Their
comments were incorporated into the elaboration document.
DISCUSSION
Here, the development of an extension to the STROBE
statement for reporting observational studies in veterinary
research is described. The intention of these guidelines, in
concordance with the STROBE statement, is to provide
guidance for authors when describing the design and results
of observational studies. The guidelines are also useful for
editors, peer reviewers, and readers of observational study
reports. It is intended that these guidelines will be applicable
to the broad range of research questions addressed in
veterinary medicine using observational studies, including
studies in which the objective was to describe disease
occurrence, exploratory studies used to generate hypotheses,
and hypothesis-driven studies. The guidelines are applicable
to research conducted in both developed and developing
nations. It is not the intention for these guidelines to be
prescriptive regarding format or order of reporting based on
the item numbering. The items in the STROBE-Vet
expansion were ordered to correspond to the items in the
STROBE statement, which follows the typical order of
sections within a scientific manuscript. It is important that all
of the relevant checklist items are addressed in sufficient
detail within a manuscript.
The STROBE-Vet guidelines are also not intended to be
prescriptive about the conduct of observational studies, but
rather they focus on the clarity of reporting similar to that of
the STROBE statement (22). Likewise, the STROBE-Vet
statement is also not intended to be used as a tool to assess
the quality of the research design or execution (24). Both the
issue of prescriptive design and use for quality assessment
have been identified in the literature as misuses of the
STROBE statement (2). There are several systematic
reviews published on quality assessment tools for observa-
tional research (7, 16, 20).
The guidelines presented herein represent the consensus
of a group of individuals deemed to be experts in
observational studies in veterinary research; and, thus, the
results represent expert opinion. A systematic review of
published literature was not conducted for any of the items,
and published evidence was not always available to support
modification to or inclusion of an item. The steering
committee attempted to balance content expertise and, to
some extent, geographical location of the selected partici-
pants. However, the existing networks of the steering
committee members influenced participant selection, the
necessity for the experts to self-fund their travel resulted in a
predominance of North American experts, and the steering
committee members knew each other professionally prior to
this initiative. Therefore, there is the potential for selection
bias to have impacted our results. We expect that these
guidelines will evolve over time, and we welcome
comments or suggestions. When used in conjunction with
the Explanation and Elaboration document, we expect that
these guidelines will lead to improved reporting of
observational research in veterinary medicine.
PARTICIPATING MEMBERS OF THE CONSENSUS
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